Cargando…
Augmentation of the Riboflavin-Biosynthetic Pathway Enhances Mucosa-Associated Invariant T (MAIT) Cell Activation and Diminishes Mycobacterium tuberculosis Virulence
Mucosa-associated invariant T (MAIT) cells play a critical role in antimicrobial defense. Despite increased understanding of their mycobacterial ligands and the clinical association of MAIT cells with tuberculosis (TB), their function in protection against Mycobacterium tuberculosis infection remain...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8844931/ https://www.ncbi.nlm.nih.gov/pubmed/35164552 http://dx.doi.org/10.1128/mbio.03865-21 |
_version_ | 1784651572769193984 |
---|---|
author | Dey, Ruchi Jain Dey, Bappaditya Harriff, Melanie Canfield, Elizabeth T. Lewinsohn, David M. Bishai, William R. |
author_facet | Dey, Ruchi Jain Dey, Bappaditya Harriff, Melanie Canfield, Elizabeth T. Lewinsohn, David M. Bishai, William R. |
author_sort | Dey, Ruchi Jain |
collection | PubMed |
description | Mucosa-associated invariant T (MAIT) cells play a critical role in antimicrobial defense. Despite increased understanding of their mycobacterial ligands and the clinical association of MAIT cells with tuberculosis (TB), their function in protection against Mycobacterium tuberculosis infection remains unclear. Here, we show that overexpressing key genes of the riboflavin-biosynthetic pathway potentiates MAIT cell activation and results in attenuation of M. tuberculosis virulence in vivo. Further, we observed greater control of M. tuberculosis infection in MAIT(hi) CAST/EiJ mice than in MAIT(lo) C57BL/6J mice, highlighting the protective role of MAIT cells against TB. We also endogenously adjuvanted Mycobacterium bovis BCG with MR1 ligands via overexpression of the lumazine synthase gene ribH and evaluated its protective efficacy in the mouse model of M. tuberculosis infection. Altogether, our findings demonstrate that MAIT cells confer host protection against TB and that overexpression of genes in the riboflavin-biosynthetic pathway attenuates M. tuberculosis virulence. Enhancing MAIT cell-mediated immunity may also offer a novel approach toward improved vaccines against TB. |
format | Online Article Text |
id | pubmed-8844931 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | American Society for Microbiology |
record_format | MEDLINE/PubMed |
spelling | pubmed-88449312022-02-17 Augmentation of the Riboflavin-Biosynthetic Pathway Enhances Mucosa-Associated Invariant T (MAIT) Cell Activation and Diminishes Mycobacterium tuberculosis Virulence Dey, Ruchi Jain Dey, Bappaditya Harriff, Melanie Canfield, Elizabeth T. Lewinsohn, David M. Bishai, William R. mBio Research Article Mucosa-associated invariant T (MAIT) cells play a critical role in antimicrobial defense. Despite increased understanding of their mycobacterial ligands and the clinical association of MAIT cells with tuberculosis (TB), their function in protection against Mycobacterium tuberculosis infection remains unclear. Here, we show that overexpressing key genes of the riboflavin-biosynthetic pathway potentiates MAIT cell activation and results in attenuation of M. tuberculosis virulence in vivo. Further, we observed greater control of M. tuberculosis infection in MAIT(hi) CAST/EiJ mice than in MAIT(lo) C57BL/6J mice, highlighting the protective role of MAIT cells against TB. We also endogenously adjuvanted Mycobacterium bovis BCG with MR1 ligands via overexpression of the lumazine synthase gene ribH and evaluated its protective efficacy in the mouse model of M. tuberculosis infection. Altogether, our findings demonstrate that MAIT cells confer host protection against TB and that overexpression of genes in the riboflavin-biosynthetic pathway attenuates M. tuberculosis virulence. Enhancing MAIT cell-mediated immunity may also offer a novel approach toward improved vaccines against TB. American Society for Microbiology 2022-02-15 /pmc/articles/PMC8844931/ /pubmed/35164552 http://dx.doi.org/10.1128/mbio.03865-21 Text en Copyright © 2022 Dey et al. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Research Article Dey, Ruchi Jain Dey, Bappaditya Harriff, Melanie Canfield, Elizabeth T. Lewinsohn, David M. Bishai, William R. Augmentation of the Riboflavin-Biosynthetic Pathway Enhances Mucosa-Associated Invariant T (MAIT) Cell Activation and Diminishes Mycobacterium tuberculosis Virulence |
title | Augmentation of the Riboflavin-Biosynthetic Pathway Enhances Mucosa-Associated Invariant T (MAIT) Cell Activation and Diminishes Mycobacterium tuberculosis Virulence |
title_full | Augmentation of the Riboflavin-Biosynthetic Pathway Enhances Mucosa-Associated Invariant T (MAIT) Cell Activation and Diminishes Mycobacterium tuberculosis Virulence |
title_fullStr | Augmentation of the Riboflavin-Biosynthetic Pathway Enhances Mucosa-Associated Invariant T (MAIT) Cell Activation and Diminishes Mycobacterium tuberculosis Virulence |
title_full_unstemmed | Augmentation of the Riboflavin-Biosynthetic Pathway Enhances Mucosa-Associated Invariant T (MAIT) Cell Activation and Diminishes Mycobacterium tuberculosis Virulence |
title_short | Augmentation of the Riboflavin-Biosynthetic Pathway Enhances Mucosa-Associated Invariant T (MAIT) Cell Activation and Diminishes Mycobacterium tuberculosis Virulence |
title_sort | augmentation of the riboflavin-biosynthetic pathway enhances mucosa-associated invariant t (mait) cell activation and diminishes mycobacterium tuberculosis virulence |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8844931/ https://www.ncbi.nlm.nih.gov/pubmed/35164552 http://dx.doi.org/10.1128/mbio.03865-21 |
work_keys_str_mv | AT deyruchijain augmentationoftheriboflavinbiosyntheticpathwayenhancesmucosaassociatedinvarianttmaitcellactivationanddiminishesmycobacteriumtuberculosisvirulence AT deybappaditya augmentationoftheriboflavinbiosyntheticpathwayenhancesmucosaassociatedinvarianttmaitcellactivationanddiminishesmycobacteriumtuberculosisvirulence AT harriffmelanie augmentationoftheriboflavinbiosyntheticpathwayenhancesmucosaassociatedinvarianttmaitcellactivationanddiminishesmycobacteriumtuberculosisvirulence AT canfieldelizabetht augmentationoftheriboflavinbiosyntheticpathwayenhancesmucosaassociatedinvarianttmaitcellactivationanddiminishesmycobacteriumtuberculosisvirulence AT lewinsohndavidm augmentationoftheriboflavinbiosyntheticpathwayenhancesmucosaassociatedinvarianttmaitcellactivationanddiminishesmycobacteriumtuberculosisvirulence AT bishaiwilliamr augmentationoftheriboflavinbiosyntheticpathwayenhancesmucosaassociatedinvarianttmaitcellactivationanddiminishesmycobacteriumtuberculosisvirulence |